Treatment strategies in Parkinson's disease (PD) can improve a patient's quality of life but
cannot stop the progression of PD. The investigators are looking for different alternatives
that modify the natural course of the disease and recent research has demonstrated the
neuroprotective properties of erythropoietin. In Cuba, the Center for Molecular Immunology
(CIM) is a cutting edge scientific center where the recombinant form (EPOrh) and recombinant
human erythropoietin with low sialic acid (NeuroEPO) are produced.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
International Center for Neurological Restoration, Cuba
Collaborators:
Center of Molecular Immunology, Cuba University of Electronic Science and Technology of China